• Berk, P.D., Goldberg, J.D., Donovan, P.B., Fruchtman, S.M., Berlin, N.I. & Wasserman, L.R. (1986) Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Seminars in Hematology, 23, 132143.
  • Besses, C., Cervantes, F., Pereira, A., Florensa, L., Solé, F., Hernández-Boluda, J.C., Woessner, S., Sans-Sabrafén, J., Rozman, C. & Montserrat, E. (1999) Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients. Leukemia, 13, 150154.
  • Brière, J. & El-Kassar, N. (1998) Clonality markers in polycythemia and primary thrombocythemia. Baillière's Clinical Haematology, 11, 787801.
  • Cervantes, F., Pereira, A., Esteve, J., Rafel, M., Cobo, F., Rozman, C. & Montserrat, E. (1997) Identification of ‘short-lived’ and ‘long-lived’ patients at presentation of primary myelofibrosis. British Journal of Haematology, 97, 635640.
  • Chistolini, A., Mazzuconi, M.G., Ferrari, A., La Verde, G., Ferraza, G., Dragoni, F., Vitale, A., Arcieri, R. & Mandelli, F. (1990) Essential thrombocythemia: a retrospective study on the clinical course of 100 patients. Haematologica, 75, 537540.
  • Cortelazzo, S., Viero, P., Finazzi, G., D'Emilio, A., Rodeghiero, G. & Barbui, T. (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. Journal of Clinical Oncology, 8, 556562.
  • Emilia, G., Sacchi, S., Temperani, P., Longo, R. & Vecchi, A. (1993) Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis. Leukemia and Lymphoma, 9, 423426.
  • Fialkow, P.J., Faguet, G.B., Jacobson, R.J., Vaidya, K. & Murphy, S. (1981) Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood, 58, 916919.
  • Guardiola, Ph, Anderson, J.E., Bandini, G., Cervantes, F., Runde, V., Arcese, W., Bacigalupo, A., Przepiorka, D., O'Donnell, M.R., Polchi, P., Buzyn, A., Sutton, L., Cazals-Hazem, D., Sale, G., De Witte, T., Deeg, J. & Gluckman, E. (1999) Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto de Midollo Osseo, and Fred Hutchinson Cancer Research Center collaborative study. Blood, 93, 28312838.
  • Harrison, C.N., Gale, R.E., Machin, S.J. & Linch, D.C. (1999) A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood, 93, 417424.
  • Kaplan, G.I. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457463.
  • Liberato, N.L., Barosi, G., Costa, A., D'Elia, P. & Bocaccio, P. (1989) Myelofibrosis with myeloid metaplasia following essential thrombocythaemia. Acta Haematologica, 82, 150153.
  • Murphy, S. (1999) Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia. Seminars in Hematology, 36, 913.
  • Murphy, S., Iland, H., Rosenthal, D. & Laszlo, J. (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Seminars in Hematology, 23, 177182.
  • Murphy, S., Peterson, P., Iland, H. & Laszlo, J. (1997) Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Seminars in Hematology, 34, 2939.
  • Pearson, T.C. (1991) Primary thrombocythaemia: diagnosis and management. British Journal of Haematology, 78, 145148.
  • Reilly, J.T. (1997) Idiopathic myelofibrosis: pathogenesis, natural history and management. Blood Reviews, 11, 233242.
  • Rozman, C., Giralt, M., Feliu, F., Rubio, D. & Cortés, M.T. (1991) Life expectancy of patients with chronic non-leukemic myeloproliferative disorders. Cancer, 67, 26582663.
  • Tefferi, A. (2001) Recent progress in the pathogenesis and management of essential thrombocythemia. Leukemia Research, 25, 369377.DOI: 10.1016/S0145-2126(00)00131-4
  • Tefferi, A., Silverstein, M.N. & Hoagland, H.C. (1995) Primary thrombocythemia. Seminars in Oncology, 22, 334340.
  • Thiele, J., Pierre, R., Imbert, M., Vardiman, J.W., Brunning, R.D. & Flandrin, G. (2001a) Chronic idiopathic myelofibrosis. In: Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (ed. by E.S.Jaffe, N.L.Harris, H.Stein & J.W. Vardiman), pp. 3538. IARC Press, Lyon.
  • Thiele, J., Kvasnicka, H.M., Zankovich, R. & Diehl, V. (2001b) Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis. Annals of Hematology, 80, 160165.
  • Van de Pette, J.E.W., Prochazka, A.V., Pearson, T.C., Singh, A.K., Dickson, E.R. & Wetherley-Mein, G. (1986) Primary thrombocythaemia treated with busulphan. British Journal of Haematology, 62, 229237.
  • Van Genderen, P.J.J., Mulder, P.G.H., Waleber, M., Van De Moesdijk, D. & Michiels, J.J. (1997) Prevention and treatment of thrombotic complications in essential thrombocythaemia: efficacy and safety of aspirin. British Journal of Haematology, 97, 179184.
  • Watson, K.V. & Key, N. (1993) Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors. British Journal of Haematology, 83, 198203.